Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results
Provided By GlobeNewswire
Last update: Aug 16, 2023
ACTON, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, announced financial results for the six months ended June 30, 2023.
